A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus

Clinical trial NCT04754334 · TERMINATED

Trial details

NCT number: NCT04754334
Sponsor: Oramed, Ltd.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

T2DM (Type 2 Diabetes Mellitus)

Start date: 2021-03-16
Primary completion: 2023-01-13
Enrollment: 346

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.